English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Regulatory

+ Regulatory
Robert Hadley | Nov 8, 2017

Europe agency approves expanded use of Bristol-Myers Squibb’s Opdivo to treat advanced melanoma

+ Community
Robert Hadley | Nov 7, 2017

Flu more likely to send people in poverty to hospital, Vanderbilt study says

+ Technology/Innovation
Robert Hadley | Nov 7, 2017

FDA fast-tracking review for AbbVie’s endometriosis drug

+ Community
John Breslin | Nov 7, 2017

Merger of Parkinson's support groups will better serve patients, chief executive says

+ Technology/Innovation
Mark Iandolo | Nov 3, 2017

Wake Forest Baptist Medical Center details treatment options for migraine sufferers

+ Community
Mark Iandolo | Nov 3, 2017

Community events slated for people with autoimmune liver disease

+ Community
Carol Ostrow | Nov 3, 2017

NIH grants to fund studies focusing on ethics in brain research

+ Community
Mark Iandolo | Nov 3, 2017

Stony Brook University Medical Center to hold neuroscience symposium

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns

  • « First
  • «
  • …
  • 363
  • 364
  • 365
  • 366
  • 367
  • 368
  • 369
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily